Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory PathwayPRNewsWire • 11/29/21
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate StrategyPRNewsWire • 10/26/21
Unicycive Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferencePRNewsWire • 09/07/21